Clinical Trial Update: MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining MRI findings and neurodevelopment in preterm infants treated with high-dose caffeine for apnea of prematurity; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity
• Brain Injury
• Intraventricular Hemorrhage

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Apnea of Prematurity, Intraventricular Hemorrhage | Phase 4 | Status: COMPLETED | Results posted: 2016-02-24